Clinical Trials Browser

Neoplasm Metastasis × trifluridine tipiracil drug combination × Clear all

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT05476796 2024-10-24

LOGICAN

Phase 2 Recruiting

118 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT04999761 2024-09-25

AB122 Platform Study

Phase 1 Recruiting

917 enrolled

GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

NCT02860546 2024-09-03

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Phase 2 Completed

18 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT05223673 2024-08-20

COLSTAR

Phase 3 Terminated

7 enrolled 12 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03274882 2024-07-25

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

Phase 2 Completed

26 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT02920476 2022-06-23

UF-STO-LUNG-003

Phase 2 Completed

4 enrolled 8 charts

Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT02921737 2021-02-04

UF-STO-PANC-003

Phase 2 Terminated

7 enrolled 12 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT03909724 2020-11-13

SUNRISE-CRC

Phase 2/3 Unknown

60 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01896856 2020-10-06

Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer

Phase 1/2 Completed

118 enrolled 16 charts

Tumor-Agnostic

Neoplasm Metastasis

Clinical Trials

INTEGRATEIIb

LOGICAN

AB122 Platform Study

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

COLSTAR

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

UF-STO-LUNG-003

UF-STO-PANC-003

SUNRISE-CRC

Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer